Genetic testing for Parkinson's disease in Israel: Insights from the Rostock Parkinson's Disease (ROPAD) study.
Anis S, Weill C, Ponger P, Nassar M, Reiner J, Chorin O, Parlar SC, Alcalay RN, Gan-Or Z, Ezra A, Saar A, Thaler A, Cohen OS, Zlotnik Y, Benizri S, Nitsan Z, Djaldetti R, Yahalom G, Schlesinger I, Klein C, Paul JJ, Curado F, Oren L, Iftikhar S, Bauer P, Gurevich T, Arkadir D, Hassin-Baer S, Greenbaum L.
Anis S, et al.
Parkinsonism Relat Disord. 2025 Aug;137:107940. doi: 10.1016/j.parkreldis.2025.107940. Epub 2025 Jun 28.
Parkinsonism Relat Disord. 2025.
PMID: 40617169
Free article.
Seven participants, including one with a positive PDGT, had positive testing findings in genes related to dystonia (GCH1 and TOR1A) and dementia (MAPT). CONCLUSIONS: Genetic testing for Israeli PD patients is beneficial, while the yield is primarily attributed to LRRK2 and …
Seven participants, including one with a positive PDGT, had positive testing findings in genes related to dystonia (GCH1 and TOR1A) a …